Statistics for Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
Total visits
| views | |
|---|---|
| Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial | 141 |
Total visits per month
| views | |
|---|---|
| October 2023 | 0 |
| November 2023 | 0 |
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
File Visits
| views | |
|---|---|
| nihms799245.pdf | 192 |
Top country views
| views | |
|---|---|
| United States | 114 |
| Germany | 4 |
| Ukraine | 3 |
| Canada | 2 |
| China | 2 |
| Vietnam | 2 |
| France | 1 |
| United Kingdom | 1 |
| Italy | 1 |
| Malaysia | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 48 |
| Fairfield | 14 |
| Houston | 11 |
| Jacksonville | 4 |
| Cambridge | 3 |
| Kiev | 3 |
| Kiez | 3 |
| Dong Ket | 2 |
| Indianapolis | 2 |
| Toronto | 2 |
| Washington | 2 |
| Ann Arbor | 1 |
| Beijing | 1 |
| Bloomsbury | 1 |
| Catanzaro | 1 |
| Commack | 1 |
| Elmshorn | 1 |
| Lanham | 1 |
| Norwalk | 1 |
| Paris | 1 |
| Seremban | 1 |
| Shenzhen | 1 |
| Stockholm | 1 |